Key Takeaways CVS' diversified model and expanded healthcare offerings drove a 64% stock gain year to date.CVS shows progress at Aetna with Medicare gains, plan optimization and AI tools improving member experience.CVS progresses with CostVantage, easing reimbursement pressures and aligning pharmacy pricing.CVS Health (CVS) appears to be attractively valued at present, as reflected in its Value Score of B. The stock has a forward five-year price-to-sales (P/S) ratio of 0.23, below its median of 0.29 and the ...